How Our Technology Works
Disease-Specific Protease Activity
Specific proteases, or enzymes that break down proteins, are fundamental to specific diseases. Changes in protease activity can be correlated to disease progression.
Measuring Proteases with Tunable Biosensors
Glympse’s biosensors include peptide molecules that are specifically cleaved by disease-specific proteases. By measuring this interaction, we can determine the activity of each protease.
Clinically Actionable Results
Glympse uses a proprietary machine learning algorithm to translate disease-specific protease activity data into clinically actionable information. This allows accurate, real-time tracking of disease progression.
Noninvasive Diagnosis & Monitoring
The lead indication for the platform is NASH, which is currently diagnosed through an invasive liver biopsy procedure. The biosensors can accurately measure liver protease activity from a simple, noninvasive blood draw.
